Review

dementia scale revised points (Hasegawa Co Ltd)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Hasegawa Co Ltd dementia scale revised points
Dementia Scale Revised Points, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/point+scale/dementia+scale/pmc12907741-4-1-0
Average 86 stars, based on 1 article reviews

dementia scale revised points - by Bioz Stars, 2026-11

86/100 stars

Images

other:

Article Title: Home-based evaluation of sleep-related breathing disorders and physical activity in older adults requiring long-term care.
Article Snippet: (OSAS), a clinically significant SRBD, has a prevalence of approximately 3%–4% in countries such as South Korea and China [2, 3].. However, OSAS is increasingly recognised in Japan, with a Japanese study involving 322 participants reporting that 22.3% of them met the criteria for OSAS [4].. Moreover, a large-scale epidemiological study revealed that the mortality rate for patients aged > 18 years with untreated moderate-to-severe OSAS was approximately 40% [5].

Article Title: Prevalence and Correlates of Mild Cognitive Impairment in Older Outpatients: A Cross-Sectional Study
Article Snippet: A Thai urban community study using the Montreal Cognitive Assessment reported 33.9% prevalence among adults aged 30 to 65 years, while a Myanmar study using the Revised Hasegawa’s Dementia Scale found 29.9% among those aged ≥60.

Transgenic Assay:

Article Title: Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives.
Article Snippet: .. Abbreviations The following abbreviations are used in this manuscript: AD Alzheimer’s disease ALS Amyotrophic lateral sclerosis AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid APP Amyloid precursor protein ATRA All-trans retinoic acid Aβ Beta-amyloid BACE-1 Beta-site APP cleaving enzyme 1 CNS Central nervous system https://doi.org/10.3390/nu18060995 CoQ10 Coenzyme Q10 DOPAL 3,4-Dihydroxyphenylacetaldehyde DPR Dipeptide repeat proteins EAAT2 Excitatory amino acid transporter 2 E2 Estradiol GABA Gamma-aminobutyric acid GDNF Glial cell line-derived neurotrophic factor HDS Hasegawa Dementia Scale IM Intramuscular IU International units LB Lewy bodies LRP1 Low-density lipoprotein receptor-related protein 1 MMSE Mini-Mental State Examination NaCl Sodium chloride NGF Nerve growth factor NFT Neurofibrillary tangles PD Parkinson’s disease RA Retinoic acid RAGE Receptor for advanced glycation end products RAR Retinoic acid receptor RCT Randomized controlled trial ROS Reactive oxygen species RXR Retinoid X receptor SAH S-adenosylhomocysteine SAM S-adenosylmethionine SNpc Substantia nigra pars compacta SOD1ˆG93A Superoxide dismutase 1 (G93A) transgenic mouse model SVCT2 Sodium-dependent vitamin C transporter 2 TPP Thiamine pyrophosphate VDR Vitamin D receptor α-syn Alpha-synuclein ..

RIA Assay:

Article Title: Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives.
Article Snippet: .. After a 16-week intervention, cognitive performance was assessed using the Hasegawa Dementia Scale (HDS) and the Mini-Mental State Examination (MMSE), while radioimmunoassay (RIA) was used to measure Aβ and estradiol (E2) levels. ..

Article Title: Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives
Article Snippet: .. After a 16-week intervention, cognitive performance was assessed using the Hasegawa Dementia Scale (HDS) and the Mini-Mental State Examination (MMSE), while radioimmunoassay (RIA) was used to measure Aβ and estradiol (E2) levels. ..